📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Hemosphere

1.1 - Company Overview

Hemosphere Logo

Hemosphere

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of proprietary graft-based vascular access solutions for dialysis, marketing the HeRO (Hemodialysis Reliable Outflow) Graft, a fully subcutaneous arteriovenous access solution for end-stage renal disease hemodialysis patients with limited access options and central venous obstruction, designed to maintain long-term access without venous anastomosis.

Products and services

  • HeRO Graft: Proprietary, fully subcutaneous arteriovenous access product engineered for ESRD hemodialysis patients with central venous stenosis, maintaining long-term access without venous anastomosis despite central venous obstruction
  • HeRO Graft Development and Marketing: Commercial program that develops and markets the proprietary graft-based HeRO arteriovenous access product for ESRD hemodialysis patients with limited access options and central venous obstruction
  • Dialysis Vascular Access Specialization: Commercial focus on vascular access for dialysis patients, addressing ESRD cases with central venous stenosis and obstruction through proprietary graft-based arteriovenous access maintained without venous anastomosis

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Hemosphere

Morphogen-IX Logo

Morphogen-IX

HQ: United Kingdom Website
  • Description: Provider of drug discovery developing bone morphogenetic proteins as a novel therapy for pulmonary arterial hypertension, a severe, life-limiting disease affecting lung blood vessels and leading to heart failure; founded in 2015 by Index Ventures.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Morphogen-IX company profile →
Innovative Cardiovascular Solutions Logo

Innovative Cardiovascular Solutions

HQ: United States Website
  • Description: Provider of novel solutions for full capture and protection from embolic material released during left-sided heart procedures.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Innovative Cardiovascular Solutions company profile →
CV Ingenuity Logo

CV Ingenuity

HQ: United States Website
  • Description: Provider of drug-coated balloon platforms for the “Touch-and-Go” treatment of vascular diseases, developing devices to relieve vascular obstructions, inhibit restenosis, and enable natural vessel healing; Palo Alto, CA-based.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CV Ingenuity company profile →
ivWatch Logo

ivWatch

HQ: United States Website
  • Description: Provider of intravenous infiltration detection solutions, including the ivWatch Monitoring System that continuously monitors peripheral IVs to detect infiltrations and extravasations early with real-time notifications to clinicians; SmartTouch single-use sensor and reusable optical fiber sensor for flexible, comfortable, MRI-compatible IV site monitoring; and OEM solutions to embed the technology into patient monitors or infusion pumps.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ivWatch company profile →
JenaValve Logo

JenaValve

HQ: United States Website
  • Description: Provider of transcatheter heart valve solutions, including the Trilogy Heart Valve System for TAVR to treat severe aortic regurgitation or stenosis, featuring a self-expanding nitinol frame and locator technology for precise placement. Offers the Trilogy Valve for secure anchoring without calcium, a Delivery System for precise deployment, and an 85cm pre-shaped Introducer Sheath for safe vascular access.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full JenaValve company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Hemosphere

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Hemosphere

2.2 - Growth funds investing in similar companies to Hemosphere

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Hemosphere

4.2 - Public trading comparable groups for Hemosphere

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Hemosphere

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Hemosphere

What does Hemosphere do?

Hemosphere is a provider of proprietary graft-based vascular access solutions for dialysis, marketing the HeRO (Hemodialysis Reliable Outflow) Graft, a fully subcutaneous arteriovenous access solution for end-stage renal disease hemodialysis patients with limited access options and central venous obstruction, designed to maintain long-term access without venous anastomosis.

Who are Hemosphere's competitors?

Hemosphere's competitors and similar companies include Morphogen-IX, Innovative Cardiovascular Solutions, CV Ingenuity, ivWatch, and JenaValve.

Where is Hemosphere headquartered?

Hemosphere is headquartered in United States.

How many employees does Hemosphere have?

Hemosphere has 1,000 employees 🔒.

When was Hemosphere founded?

Hemosphere was founded in 2010 🔒.

What sector and industry vertical is Hemosphere in?

Hemosphere is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Hemosphere

Who are the top strategic acquirers in Hemosphere's sector and industry

Top strategic M&A buyers and acquirers in Hemosphere's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Hemosphere?

Top strategic M&A buyers groups and sectors for Hemosphere include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Hemosphere's sector and industry vertical

Which are the top PE firms investing in Hemosphere's sector and industry vertical?

Top PE firms investing in Hemosphere's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Hemosphere's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Hemosphere's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Hemosphere's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Hemosphere include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Hemosphere's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Hemosphere?

The key public trading comparables and valuation benchmarks for Hemosphere include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Hemosphere for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Hemosphere with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Hemosphere's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Hemosphere with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Hemosphere's' sector and industry vertical?

Access recent funding rounds and capital raises in Hemosphere's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Hemosphere